The Manufacturers Life Insurance Company grew its position in West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 8.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 69,046 shares of the medical instruments supplier’s stock after acquiring an additional 5,465 shares during the quarter. The Manufacturers Life Insurance Company owned approximately 0.09% of West Pharmaceutical Services worth $22,743,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also made changes to their positions in the company. Steward Partners Investment Advisory LLC raised its holdings in shares of West Pharmaceutical Services by 108.5% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 738 shares of the medical instruments supplier’s stock worth $260,000 after purchasing an additional 384 shares during the period. CWA Asset Management Group LLC acquired a new stake in West Pharmaceutical Services during the fourth quarter worth about $250,000. NEOS Investment Management LLC lifted its holdings in West Pharmaceutical Services by 163.8% in the fourth quarter. NEOS Investment Management LLC now owns 1,965 shares of the medical instruments supplier’s stock worth $692,000 after acquiring an additional 1,220 shares during the last quarter. Blueshift Asset Management LLC boosted its stake in West Pharmaceutical Services by 189.7% in the fourth quarter. Blueshift Asset Management LLC now owns 1,799 shares of the medical instruments supplier’s stock valued at $633,000 after acquiring an additional 1,178 shares during the period. Finally, Copperwynd Financial LLC grew its holdings in shares of West Pharmaceutical Services by 4.0% during the fourth quarter. Copperwynd Financial LLC now owns 778 shares of the medical instruments supplier’s stock valued at $274,000 after purchasing an additional 30 shares during the last quarter. 93.90% of the stock is owned by institutional investors and hedge funds.
West Pharmaceutical Services Trading Down 0.1 %
Shares of NYSE WST opened at $299.72 on Wednesday. West Pharmaceutical Services, Inc. has a 12-month low of $265.00 and a 12-month high of $413.70. The company has a market cap of $21.74 billion, a price-to-earnings ratio of 39.54, a price-to-earnings-growth ratio of 11.09 and a beta of 1.01. The company has a current ratio of 2.34, a quick ratio of 1.68 and a debt-to-equity ratio of 0.03. The stock’s 50 day simple moving average is $301.24 and its 200 day simple moving average is $333.73.
Insider Buying and Selling at West Pharmaceutical Services
In related news, VP Charles Witherspoon sold 1,029 shares of the stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $300.00, for a total value of $308,700.00. Following the completion of the transaction, the vice president now directly owns 1,478 shares of the company’s stock, valued at approximately $443,400. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.53% of the stock is owned by company insiders.
About West Pharmaceutical Services
West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
Recommended Stories
- Five stocks we like better than West Pharmaceutical Services
- What is Insider Trading? What You Can Learn from Insider Trading
- Why Lennar Stock Could Be the Best Play in the Housing Market
- What Does a Stock Split Mean?
- 2 Energy Stocks Fueling the AI Datacenter Boom
- What is Forex and How Does it Work?
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.